Tudor Investment Corp’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Tudor Investment Corp’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-16,965	Closed	-$3.82M	–	2958
2022 Q3	$3.82M	Buy	16,965 +2,038	+14%	+$412K	0.08%	288
2022 Q2	$1.89M	Buy	+14,927	New	+$1.72M	0.05%	540
2021 Q4	–	Sell	-9,906	Closed	-$1.21M	–	3150
2021 Q3	$1.21M	Buy	+9,906	New	+$1.14M	0.02%	1027
2021 Q2	–	Sell	-2,779	Closed	-$334K	–	2034
2021 Q1	$334K	Buy	+2,779	New	+$315K	0.01%	1274

Other funds holding KRTX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Tudor Investment Corp's KRTX Position: Q4 2022 in Review

Tudor Investment Corp sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q4 2022, closing a stake of 16,965 shares — an estimated $3.82M sold.

Tudor Investment Corp first reported a position in KRTX in Q1 2021 and held it in 4 quarters. The position peaked at $3.82M in Q3 2022. 248 funds tracked by Wall St. Rank hold KRTX as of Q4 2022.

Tudor Investment Corp reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Tudor Investment Corp sold 16,965 Karuna Therapeutics, Inc. Common Stock shares in Q4 2022, an estimated $3.82M.
Tudor Investment Corp first reported a position in Karuna Therapeutics, Inc. Common Stock in Q1 2021 and held it in 4 quarters.
Tudor Investment Corp's Karuna Therapeutics, Inc. Common Stock position peaked at $3.82M in Q3 2022.
248 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q4 2022.

Based on Tudor Investment Corp's 13F filing for Q4 2022, filed 14 Feb 2023.